MINIVELLE® (estradiol transdermal system) is a prescription medicine patch that contains estradiol (an estrogen hormone). MINIVELLE is used to treat moderate to severe hot flashes due to menopause.
What is the most important information I should know about MINIVELLE (an estrogen hormone)?
MINIVELLE should not be used if you have unusual vaginal bleeding, currently have or have had certain cancers, had a stroke or heart attack, currently have or have had blood clots, currently have or have had liver problems, have been diagnosed with a bleeding disorder, are allergic to MINIVELLE or any of its ingredients, or think you may be pregnant.
The most common side effects that may occur with MINIVELLE are headache, breast tenderness, back and limb pain, common cold, upset stomach, nausea, inflammation of the sinuses and irregular vaginal bleeding or spotting.
MINIVELLE should be used at the lowest effective dose and for the shortest duration consistent with your treatment goals and risks.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.
DOT Matrix™ is a trademark of Noven Pharmaceuticals, Inc.
Minivelle® and the Minivelle Logo are trademarks of Noven Therapeutics, LLC.
Vivelle-Dot® is a registered trademark of Novartis AG.
All other registered trademarks are the property of their respective owners.
For information, call 1‑800‑455‑8070.